Overview
Jaclyn Flanigan is a Hematologist Oncology specialist and a Hematologist in Hyannis, Massachusetts. Dr. Flanigan is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Angiosarcoma, Inflammatory Breast Cancer, Paget Disease of the Breast, and Breast Cancer. Dr. Flanigan is currently accepting new patients.
Her clinical research consists of co-authoring 3 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
27 Park St, Hyannis, MA 02601
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Dana-Farber Cancer Institute, Inc.
Robb Friedman is a Hematologist Oncology specialist and a Hematologist in South Weymouth, Massachusetts. Dr. Friedman is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Thalassemia, Essential Thrombocythemia, Waldenstrom Macroglobulinemia, and Myelodysplastic Syndrome (MDS). Dr. Friedman is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Mahesh Pandey is a Hematologist Oncology specialist and a Hematologist in South Weymouth, Massachusetts. Dr. Pandey is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Monoclonal Gammopathy of Undetermined Significance (MGUS), Colorectal Cancer, Familial Colorectal Cancer, Pleuropulmonary Blastoma, and Bone Marrow Aspiration. Dr. Pandey is currently accepting new patients.
Physicians Of Cape Cod Hospital
Peter Ward is a Hematologist Oncology specialist and a Hematologist in Hyannis, Massachusetts. Dr. Ward is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Acinic Cell Carcinoma of Salivary Glands, Salivary Gland Tumors, Colorectal Cancer, and Familial Colorectal Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AngiosarcomaDr. Flanigan isDistinguished. Learn about Angiosarcoma.
- Breast CancerDr. Flanigan isDistinguished. Learn about Breast Cancer.
- Chronic Lymphocytic Leukemia (CLL)Dr. Flanigan isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- Inflammatory Breast CancerDr. Flanigan isDistinguished. Learn about Inflammatory Breast Cancer.
- Lung CancerDr. Flanigan isDistinguished. Learn about Lung Cancer.
- MelanomaDr. Flanigan isDistinguished. Learn about Melanoma.
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- B-Cell LymphomaDr. Flanigan isAdvanced. Learn about B-Cell Lymphoma.
- Chronic B-Cell Leukemia (CBCL)Dr. Flanigan isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Colorectal CancerDr. Flanigan isAdvanced. Learn about Colorectal Cancer.
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Flanigan isAdvanced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- EGFR Positive Lung CancerDr. Flanigan isAdvanced. Learn about EGFR Positive Lung Cancer.
- Experienced
- Acquired AgranulocytosisDr. Flanigan isExperienced. Learn about Acquired Agranulocytosis.
- Acute Eosinophilic PneumoniaDr. Flanigan isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Mountain SicknessDr. Flanigan isExperienced. Learn about Acute Mountain Sickness.
- Adrenal CancerDr. Flanigan isExperienced. Learn about Adrenal Cancer.
- Adult Immune ThrombocytopeniaDr. Flanigan isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Flanigan isExperienced. Learn about Adult Soft Tissue Sarcoma.